Sie suchten nach: adrenoreceptoru (Lettisch - Englisch)

1- adrenoreceptoru
drugs within class

beta adrenoreceptoru blokatori
beta-adrenergic blockers

1-adrenoreceptoru antagonisti
1-adrenoreceptor antagonist

alfa 1- adrenoreceptoru antagonisti
alpha 1- adrenoreceptor antagonist

alfa- adrenoreceptoru blokators, atĶ kods:
alpha-adrenoceptor antagonists atc code:

alfa 1-adrenoreceptoru antagonisti: alfuzosīns;
alpha 1-adrenoreceptor antagonists: alfuzosin

alfuzosīns (alfa 1-adrenoreceptoru antagonists),
alfuzosin (alpha 1-adrenoreceptor antagonist)

ilgstošas darbības beta2-adrenoreceptoru agonisti
long-acting beta2-adrenergic agonist

formoterols ir spēcīgs selektīvs β2 adrenoreceptoru agonists.
formoterol is a potent selective β2-adrenoceptor agonist.

vilanterols ir ilgstošas darbības beta-2 adrenoreceptoru agonists.
vilanterol is a long-acting beta-2 adrenergic agonist.

mirabegrons ir spēcīgs un selektīvs beta-3 adrenoreceptoru agonists.
mirabegron is a potent and selective beta 3-adrenoceptor agonist.

sileo aktīvā viela deksmedetomidīns ir alfa-2 adrenoreceptoru agonists.
dexmedetomidine, the active ingredient of sileo is an alpha-2 adrenoceptor agonist.

lielāko daļu šo parādību izraisa alfa- 2 adrenoreceptoru agonista darbība.
most of these signs are due to alpha-2- adreno-receptor agonist effects.

beta adrenoreceptoru blokatori var pavājināt vai antagonizēt beta2 adrenoreceptoru agonistu iedarbību.
beta-adrenergic blockers may weaken or antagonise the effect of beta2-adrenergic agonists.

lielu beta2 adrenoreceptoru agonistu devu inhalācijas var paaugstināt glikozes koncentrāciju plazmā.
inhalation of high doses of beta2-adrenergic agonists may produce increases in plasma glucose.

indakaterols ir ilgstošas darbības beta2 adrenoreceptoru agonists lietošanai vienu reizi dienā.
indacaterol is a long-acting beta2-adrenergic agonist for once-daily administration.

diabēta pacientiem ir jāapsver papildu asins glikozes kontrole. β2-adrenoreceptoru agonisti
additional blood glucose controls should be considered in diabetic patients. β2 adrenoreceptor agonists

Šī iemesla dēļ nav ieteicams lietot šīs zāles vienlaikus ar citiem α-adrenoreceptoru blokatoriem.
consequently, the concomitant use of other α-adrenoreceptor antagonists is not recommended.

ir domājams, ka šo efektu izraisa selektīvo alfa- 1- adrenoreceptoru bloķēšana asinsvados.
this effect is thought to result from selective blockade of the alpha-1-adrenoceptors located in the vasculature.

farmakoterapeitiskā grupa: uroloģiski līdzekļi, alfa-adrenoreceptoru antagonisti, atĶ kods: g04ca04.
pharmacotherapeutic group: urologicals, alpha-adrenoreceptor antagonists, atc code: g04ca04.